紫杉醇治疗晚期肿瘤53例（Paclitaxel in the treatment of advanced tumors in 53 cases）.docVIP

下载本文档

0
0
约6.83千字
约 6页
2017-09-07 发布于河南
举报
版权申诉

紫杉醇治疗晚期肿瘤53例（Paclitaxel in the treatment of advanced tumors in 53 cases）.doc

1、原创力文档（book118）网站文档一经付费（服务费），不意味着购买了该文档的版权，仅供个人/单位学习、研究之用，不得用于商业用途，未经授权，严禁复制、发行、汇编、翻译或者网络传播等，侵权必究。。
2、本站所有内容均由合作方或网友上传，本站不对文档的完整性、权威性及其观点立场正确性做任何保证或承诺！文档内容仅供研究参考，付费前请自行鉴别。如您付费，意味着您自己接受本站规则且自行承担风险，本站不退款、不进行额外附加服务；查看《如何避免下载的几个坑》。如果您已付费下载过本站文档，您可以点击这里二次下载。
3、如文档侵犯商业秘密、侵犯著作权、侵犯人身权等，请点击“版权申诉”（推荐），也可以打举报电话：400-050-0827(电话支持时间：9:00-18:30)。
4、该文档为VIP文档，如果想要下载，成为VIP会员后，下载免费。
5、成为VIP后，下载本文档将扣除1次下载权益。下载后，不支持退款、换文档。如有疑问请联系我们。
6、成为VIP后，您将拥有八大权益，权益包括：VIP文档下载权益、阅读免打扰、文档格式转换、高级专利检索、专属身份标志、高级客服、多端互通、版权登记。
7、VIP文档为合作方或网友上传，每下载1次，网站将根据用户上传文档的质量评分、类型等，对文档贡献者给予高额补贴、流量扶持。如果你也想贡献VIP文档。上传文档

紫杉醇治疗晚期肿瘤53例（Paclitaxel in the treatment of advanced tumors in 53 cases）

紫杉醇治疗晚期肿瘤53例（Paclitaxel in the treatment of advanced tumors in 53 cases） Paclitaxel in the treatment of advanced tumors in 53 cases Update Date: 2011-01-22 Click: Lin Jun A total of 53 cases of ovarian cancer and breast cancer were treated with paclitaxel, and single drug therapy group and combined chemotherapy group were used to compare the efficacy of blood stasis and paclitaxel in the treatment of advanced cancer. Results: the effective rate of single drug therapy was 36.4% in ovarian cancer and 56.2% in breast cancer. The effective rate of combined chemotherapy was 58.3% in ovarian cancer and 42.8% in breast cancer. These results indicate that paclitaxel is effective in the treatment of advanced tumors. Keywords Paclitaxel; advanced tumor; curative effect; The yew is an effective component extracted from or extracted from the trunk, bark and needles of yew. Because of its unique mechanism of action and resistance to drug-resistant cells, it has received extensive attention in recent years. It is mainly involved in the microtubule / tubulin system and inhibits microtubule depolymerization, resulting in abnormal arrangement of microtubule bundles [1]. In order to observe the curative effect and side effect of paclitaxel, we performed clinical tests on 53 patients from 1996-07 to 1997-10. The results were reported as follows. 1 case selection Of the 53 cases, aged 37 to 65 years old, average 55 + 6.4 years, confirmed by pathology or cytology were objective, observation index, liver and kidney function and normal blood, within the past 1 months has not made chemotherapy and other anti-tumor therapy, KPS 60 points, is expected to survive more than 3 months and observable indicators of hospitalization in patients with advanced. Among them, 23 cases of ovarian cancer, 30 cases of breast cancer. The clinical stages were stage III to iv.. 2 treatment Before use, ask the patient if there is any history of allergies, and check the white blood cell and platelet counts. Hav